ECOR
electroCore, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$7.63
−2.80%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$7.86
From 52W high−37.92%
Volume70679.00
Market cap$68.79M
P/E (TTM)—
P/S (TTM)1.9x
Div yield—
Key dataOct 19, 2026
Open
$7.86
From 52W high
−37.92%
Volume
70679.00
Market cap
$68.79M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−5.5x
P/E (TTM)
—
RSI (14)
27.0
MomentumView details →
1D Return
−2.80%
YTD Return
+71.38%
SummaryUpdated Jun 1, 2026
electroCore, Inc. (NASDAQ:ECOR) is a commercial-stage medical device company founded in 2005 and headquartered in Rockaway, New Jersey. The company specializes in developing and commercializing non-invasive vagus nerve stimulation (nVNS) therapies through its flagship gammaCore technology platform. Since going public in 2018, electroCore has expanded beyond prescription medical devices into direct-to-consumer wellness products and military performance applications. In 2024, the company strategically acquired NeuroMetrix to broaden its bioelectronic health portfolio, positioning itself as a diversified player in the emerging field of bioelectronic medicine.
Similar companies
Latest newsMore news →
Mike Fox was appointed Co-Chief Executive Officer and member of the Board of Directors of electroCore, Inc., effective September 8, 2026.41d agoelectroCore, Inc. reported a second-quarter loss of $0.33 per share, beating the Zacks Consensus Estimate of a loss of $0.41 and improving from a loss of $0.35 per share a year ago.74d ago